RVA-induced necrosome formation consisting of RIPK1, RIPK3, and MLKL

From (Tool)Bench to Bedside: The Potential of Necroptosis Inhibitors

Necroptosis: a regulated inflammatory mode of cell death, Journal of Neuroinflammation

MLKL in cancer: more than a necroptosis regulator. - Abstract - Europe PMC

Shikonin overcomes drug resistance and induces necroptosis by regulating the miR-92a-1-5p/MLKL axis in chronic myeloid leukemia

RIPK proteins in cell death and tissue homeostasis.

Frontiers Exploiting Necroptosis for Therapy of Acute Lymphoblastic Leukemia

MLKL in cancer: more than a necroptosis regulator. - Abstract - Europe PMC

Double agents of cell death: novel emerging functions of apoptotic regulators - Lamb - 2020 - The FEBS Journal - Wiley Online Library

RIPK1 and RIPK3 form mosaic necrosomes

Regulated Necrosis - The Linkermann Lab

RIPK3 signaling and its role in the pathogenesis of cancers

Role of Necroptosis in Central Nervous System Diseases

The regulation of necroptosis by post-translational modifications

IJMS, Free Full-Text

Shikonin overcomes drug resistance and induces necroptosis by regulating the miR-92a-1-5p/MLKL axis in chronic myeloid leukemia